Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Rhea-AI Summary

Journey Medical (Nasdaq: DERM), a commercial-stage pharmaceutical company specializing in FDA-approved prescription drugs for dermatological conditions, has announced its participation in the 3rd Annual ROTH Healthcare Opportunities Conference. The event is set to take place on Wednesday, October 9, 2024, in New York City.

Members of Journey Medical's management team will be attending one-on-one meetings during the conference. This participation highlights the company's commitment to engaging with investors and industry professionals in the healthcare sector.

The conference provides an opportunity for Journey Medical to showcase its focus on selling and marketing dermatological treatments, potentially attracting investor interest and fostering business relationships within the pharmaceutical industry.

News Market Reaction – DERM

+0.32%

1 alert

+0.32% News Effect

On the day this news was published, DERM gained 0.32%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

SCOTTSDALE, Ariz., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that members of Journey Medical’s management team will attend one-on-one meetings at the 3rd Annual ROTH Healthcare Opportunities Conference, scheduled to take place on Wednesday, October 9, 2024 in New York City.

About Journey Medical Corporation
Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”) is a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions through its efficient sales and marketing model. The Company currently markets seven branded and two generic products that help treat and heal common skin conditions. The Journey Medical team comprises industry experts with extensive experience in developing and commercializing some of dermatology’s most successful prescription brands. Journey Medical is located in Scottsdale, Arizona and was founded by Fortress Biotech, Inc. (Nasdaq: FBIO). Journey Medical’s common stock is registered under the Securities Exchange Act of 1934, as amended, and it files periodic reports with the U.S. Securities and Exchange Commission (“SEC”). For additional information about Journey Medical, visit www.journeymedicalcorp.com.

Company Contact:
Jaclyn Jaffe
(781) 652-4500
ir@jmcderm.com

Media Relations Contact:
Tony Plohoros
6 Degrees
(908) 591-2839
tplohoros@6degreespr.com

FAQ

When is Journey Medical (DERM) participating in the ROTH Healthcare Opportunities Conference?

Journey Medical (DERM) is participating in the 3rd Annual ROTH Healthcare Opportunities Conference on Wednesday, October 9, 2024.

Where will the 3rd Annual ROTH Healthcare Opportunities Conference be held?

The 3rd Annual ROTH Healthcare Opportunities Conference will be held in New York City.

What type of meetings will Journey Medical (DERM) attend at the conference?

Journey Medical 's management team will attend one-on-one meetings at the conference.

What is the primary focus of Journey Medical (DERM)?

Journey Medical primarily focuses on selling and marketing FDA-approved prescription pharmaceutical products for treating dermatological conditions.

What is Journey Medical 's stock symbol?

Journey Medical 's stock symbol is DERM, and it is listed on the Nasdaq.